Acute cortical tubular necrosis in the Swiss ICR mouse induced by 2-bromoethylamine hydrobromide

D C Wolf1, W W Carlton

  • 1Department of Veterinary Pathobiology, School of Veterinary Medicine, Purdue University, West Lafayette, IN 47907.

Insights

2-bromoethylamine hydrobromide (BEA) causes dose-dependent kidney damage in mice, primarily acute tubular necrosis. Recovery involves tubular regeneration but can lead to fibrosis and dilation.

Area of Science:

  • Toxicology
  • Nephrology
  • Pharmacology

Background:

  • 2-bromoethylamine hydrobromide (BEA) is a chemical agent with known toxic properties.
  • Understanding the dose-response and temporal effects of BEA on the kidney is crucial for risk assessment.

Purpose of the Study:

  • To investigate the dose-response relationship of 2-bromoethylamine hydrobromide (BEA)-induced nephrotoxicosis in mice.
  • To determine the sequential pathological changes in the kidney following BEA exposure.

Main Methods:

  • Swiss ICR mice were used in dose-response and sequential studies.
  • Mice received intraperitoneal injections of varying doses of BEA (100-500 mg/kg) or a control saline solution.
  • Kidneys were examined at different time points (0.5 hr to 10 days) post-injection.

Main Results:

  • Mortality and renal lesions, including tubular and papillary necrosis, were dose-dependent.
  • Acute tubular necrosis was observed as early as 2-3 hours post-BEA administration.
  • Tubular regeneration was evident by day 3, with fibrosis and dilation noted by day 10.

Conclusions:

  • BEA-induced nephrotoxicosis in mice is characterized by acute cortical tubular necrosis.
  • The severity of kidney damage is directly related to the BEA dose.
  • Long-term exposure can lead to interstitial fibrosis and tubular dilation.

Related Concept Videos